These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15013425)

  • 1. No influence of tumor growth by intramuscular injection of hepatocyte growth factor plasmid DNA: safety evaluation of therapeutic angiogenesis gene therapy in mice.
    Matsuki A; Yamamoto S; Nakagami H; Aoki M; Tamai K; Matsumoto K; Nakamura T; Ogihara T; Kaneda Y; Morishita R
    Biochem Biophys Res Commun; 2004 Feb; 315(1):59-65. PubMed ID: 15013425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
    Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced therapeutic angiogenesis by cotransfection of prostacyclin synthase gene or optimization of intramuscular injection of naked plasmid DNA.
    Hiraoka K; Koike H; Yamamoto S; Tomita N; Yokoyama C; Tanabe T; Aikou T; Ogihara T; Kaneda Y; Morishita R
    Circulation; 2003 Nov; 108(21):2689-96. PubMed ID: 14568901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle.
    Taniyama Y; Tachibana K; Hiraoka K; Aoki M; Yamamoto S; Matsumoto K; Nakamura T; Ogihara T; Kaneda Y; Morishita R
    Gene Ther; 2002 Mar; 9(6):372-80. PubMed ID: 11960313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor as potential cardiovascular therapy.
    Nakagami H; Kaneda Y; Ogihara T; Morishita R
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):513-9. PubMed ID: 15889978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets.
    Aoki M; Morishita R; Taniyama Y; Kida I; Moriguchi A; Matsumoto K; Nakamura T; Kaneda Y; Higaki J; Ogihara T
    Gene Ther; 2000 Mar; 7(5):417-27. PubMed ID: 10694824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naked DNA expressing two isoforms of hepatocyte growth factor induces collateral artery augmentation in a rabbit model of limb ischemia.
    Pyun WB; Hahn W; Kim DS; Yoo WS; Lee SD; Won JH; Rho BS; Park ZY; Kim JM; Kim S
    Gene Ther; 2010 Dec; 17(12):1442-52. PubMed ID: 20668482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice.
    Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T
    Cancer Gene Ther; 2004 Jun; 11(6):419-30. PubMed ID: 15017381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice.
    Son G; Hirano T; Seki E; Iimuro Y; Nukiwa T; Matsumoto K; Nakamura T; Fujimoto J
    J Hepatol; 2006 Nov; 45(5):688-95. PubMed ID: 16839638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy.
    Azuma J; Taniyama Y; Takeya Y; Iekushi K; Aoki M; Dosaka N; Matsumoto K; Nakamura T; Ogihara T; Morishita R
    Gene Ther; 2006 Aug; 13(16):1206-13. PubMed ID: 16625244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice.
    Saimura M; Nagai E; Mizumoto K; Maehara N; Okino H; Katano M; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
    Cancer Gene Ther; 2002 Oct; 9(10):799-806. PubMed ID: 12224019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of mouse acute colitis by naked hepatocyte growth factor gene transfer into the liver.
    Hanawa T; Suzuki K; Kawauchi Y; Takamura M; Yoneyama H; Han GD; Kawachi H; Shimizu F; Asakura H; Miyazaki J; Maruyama H; Aoyagi Y
    J Gene Med; 2006 May; 8(5):623-35. PubMed ID: 16479533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.
    Hashiya N; Jo N; Aoki M; Matsumoto K; Nakamura T; Sato Y; Ogata N; Ogihara T; Kaneda Y; Morishita R
    Circulation; 2004 Jun; 109(24):3035-41. PubMed ID: 15173033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4.
    Saimura M; Nagai E; Mizumoto K; Maehara N; Minamishima YA; Katano M; Matsumoto K; Nakamura T; Tanaka M
    Clin Cancer Res; 2002 Oct; 8(10):3243-9. PubMed ID: 12374695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced angiogenesis and improvement of neuropathy by cotransfection of human hepatocyte growth factor and prostacyclin synthase gene.
    Koike H; Morishita R; Iguchi S; Aoki M; Matsumoto K; Nakamura T; Yokoyama C; Tanabe T; Ogihara T; Kaneda Y
    FASEB J; 2003 Apr; 17(6):779-81. PubMed ID: 12586736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice.
    Yang J; Dai C; Liu Y
    Gene Ther; 2001 Oct; 8(19):1470-9. PubMed ID: 11593360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
    Saito Y; Nakagami H; Morishita R; Takami Y; Kikuchi Y; Hayashi H; Nishikawa T; Tamai K; Azuma N; Sasajima T; Kaneda Y
    Circulation; 2006 Sep; 114(11):1177-84. PubMed ID: 16952986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.
    Powell RJ; Simons M; Mendelsohn FO; Daniel G; Henry TD; Koga M; Morishita R; Annex BH
    Circulation; 2008 Jul; 118(1):58-65. PubMed ID: 18559703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin.
    Kushibiki T; Matsumoto K; Nakamura T; Tabata Y
    Gene Ther; 2004 Aug; 11(15):1205-14. PubMed ID: 15103321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research advance of gene therapy for peripheral arterial disease using hepatocyte growth factor].
    Zhang Q; Li Y; Wu Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Nov; 20(11):1147-50. PubMed ID: 17191586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.